Bo and I discuss some of the leading candidates for extending both human lifespan and “health-span”, including metformin, nicotinamide riboside & nicotinamide mononucleotide, and caloric restriction. We also chat about some of the companies working in this area, as well as novel business models that may or may not be a strategy to enable rigorous research of something as difficult to study as human lifespan.
Podden och tillhörande omslagsbild på den här sidan tillhör
Ian McLaughlin & Bo Allen. Innehållet i podden är skapat av Ian McLaughlin & Bo Allen och inte av,
eller tillsammans med, Poddtoppen.